As pharmaceutical companies expand direct-to-patient (DTP) strategies, many continue to face lengthy implementation timelines driven by fragmented technology environments, custom integrations, and complex program requirements. These delays can slow patient access, extend the time between program approval and first prescription fulfillment, and limit a brand's ability to respond quickly to market opportunities.
In this webinar, industry leaders will discuss the technology and operational factors that influence the speed, scalability, and success of DTP program launches. Panelists will explore the challenges of balancing customization with efficiency while examining how configurable platforms, reusable technology components, and API-enabled architectures can help organizations reduce implementation complexity, accelerate deployment, and support repeatable growth across brands and therapeutic areas without sacrificing flexibility or patient experience.
Attendees Will Gain Insights Into:
Jeremy Richardson is the Chief Commercial Officer of Gifthealth, where he leads all commercial strategy, new business development, and marketing functions for one of healthcare's fastest-growing technology-enabled pharmacy platforms. With more than 15 years of experience spanning sales, marketing, trade relations, and business development across both the private and public sectors, Jeremy brings a uniquely well-rounded perspective to the evolving direct-to-patient landscape.
